Doxorubicin (DOX) is a potent anti-cancer agent that has garnered great interest in research
due to its high efficacy despite dose-limiting toxicities. Several strategies have been …

Peptide–and protein–nanoparticle conjugates have emerged as powerful tools for
biomedical applications, enabling the treatment, diagnosis, and prevention of disease. In …

Standard cancer therapies sometimes fail to deliver chemotherapeutic drugs to tumor cells
in a safe and effective manner. Nanotechnology takes the lead in providing new therapeutic …

Hypoxia, a characteristic feature of tumors, is indispensable to tumor angiogenesis,
metastasis, and multi drug resistance. Hypoxic avascular regions, deeply embedded inside …

Nanotechnology takes the lead in providing new therapeutic options for cancer patients. In
the last decades, lipid-based nanoparticles—solid lipid nanoparticles (SLNs) …

Interferon regulatory factors (IRFs) are a family of homologous proteins that regulate the
transcription of interferons (IFNs) and IFN-induced gene expression. As such they are …

Nanoparticles (NPs) are promising drug delivery systems (DDS) for identifying and treating
cancer. Active targeting NPs can be generated by conjugation with ligands that bind …

Delivery of siRNA is a key hurdle to realizing the therapeutic promise of RNAi. By targeting
internalizing cell surface antigens, antibody–siRNA complexes provide a possible solution …

Breast cancer is the most common invasive tumor in women and the second leading cause
of cancer-related death. Nanomedicine raises high expectations for millions of patients as it …

Mycotoxins are toxic secondary metabolites produced by certain filamentous fungi. The
occurrence of mycotoxins in food and feed causes negative health impacts on both humans …